enVVeno Medical Corp. (NVNO) intrinsic value & 10-year financials
enVVeno Medical Corp. (NVNO) has a Graham intrinsic value of $3,909.84 per share. At $7.47 on Oct 17, 2026, the stock trades 100% below that value.
- Graham intrinsic value
- $3,909.84
- Share price (Oct 17, 2026)
- $7.47
- Price vs Graham value
- 100% below
- Market cap
- $4.4M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- -72.8%
- ROIC (10-yr avg)
- 409.4%
- Free cash flow (FY2025)
- -$15.6M
NVNO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$19.5M | -$33.06 | -$15.6M | — | -59.5% |
| FY2024 | — | -$21.8M | -$1.27 | -$16.9M | — | -51.5% |
| FY2023 | — | -$23.5M | -$1.91 | -$18.9M | — | -59.4% |
| FY2022 | — | -$24.7M | -$2.20 | -$15.7M | — | -133.5% |
| FY2021 | — | -$16.5M | — | -$12.2M | — | 5587.1% |
| FY2020 | — | -$9.1M | — | -$7.9M | — | 1054.7% |
| FY2019 | $31.2K | -$7.6M | — | -$6.3M | -24566.5% | -3042.2% |
| FY2018 | $186.6K | -$13.0M | — | -$6.4M | -4210.5% | 286.8% |
| FY2017 | $422.1K | -$7.8M | — | -$4.2M | -1445.9% | 101.5% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
enVVeno Medical Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
enVVeno Medical Corp has historically struggled to out-earn its cost of capital, averaging just -18.2% ROIC.
enVVeno Medical Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, enVVeno Medical Corp is modeled at -72.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $3909.84 per share.